Vasomune Therapeutics

1 Follower


Vasomune Therapeutics is a private biotechnology company developing the next generation of medicine. Our innovative approach focuses on combating vascular dysfunction and defending against illness by modifying the body’s cellular response to disease.

Douglas A. Hamilton
President and CEO
Douglas A. Hamilton
Ghania Chikh
Senior Director, Non-Clinical Development
Ken Sokoll
Head of Development
Dana McClintock
Chief Medical Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.